ADC Therapeutics shareholders approve capital range increase and conditional share capital amendments

ADC Therapeutics SA

Shareholders approved amendment to Article 4a to increase capital range (52.4M for, 9.0M against).
Shareholders approved amendment to Article 4c to increase conditional share capital for financing/acquisitions (52.3M for, 9.0M against).
Amendments to articles of association became effective immediately upon approval at Nov 11, 2024 special meeting.
Broker non-votes: none reported for either proposal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.